drkoop.com forms partnership with Acurian
"This alliance gives drkoop's loyal audience an opportunity to access Acurian's up-to-date information about new medical therapies, drugs in development and clinical trials seeking patients to participate," said Richard Rosenblatt, CEO of drkoop.com. "At the same time, it allows Acurian to tap into a pre-qualified population that already has expressed interest in a specific disease."
"As the remarkable developments in genetics, genomics and other areas begin to transform medicine, the greatest challenge is to demonstrate safety and efficacy of these new drugs, and to provide information about these new treatments to the people who can benefit from them," said Leslie Michelson, CEO of Acurian. "Our pioneering relationship with drkoop.com will enable us to help all of the many people in the drkoop community become aware of clinical trials and new treatments as soon as they become available."